New perspectives on hereditary influences in metastatic progression.

Metastasis, the process by which cancer cells spread to distant sites and form secondary tumors, depends upon the ability of cells to escape the primary tumor, and colonize and proliferate in a novel microenvironment. Many mechanisms have been proposed to explain this phenomenon although no theory has comprehensively explained all biological observations. There is growing evidence that host hereditary factors modulate the ability of tumor cells to form metastatic lesions, and host genetic polymorphism could be a significant variable in this process. This review is intended to illustrate the role of hereditary variation in metastatic progression, how this integrates with currently proposed metastatic mechanisms, and the potential clinical impact on this frequently fatal consequence of cancer.

[1]  P. Pharoah,et al.  Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1 , 2005, Nature Genetics.

[2]  C. Klein,et al.  Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients. , 2001, Seminars in cancer biology.

[3]  D. Welch,et al.  Metastasis suppressor pathways--an evolving paradigm. , 2003, Cancer letters.

[4]  M. Meuth.  The structure of mutation in mammalian cells. , 1990, Biochimica et biophysica acta.

[5]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[6]  K. Hunter.  Allelic diversity in the host genetic background may be an important determinant in tumor metastatic dissemination. , 2003, Cancer letters.

[7]  E. Liu,et al.  Global Expression Profiling Identifies Signatures of Tumor Virulence in MMTV-PyMT-Transgenic Mice , 2004, Cancer Research.

[8]  Douglas F. Easton,et al.  Polygenic susceptibility to breast cancer and implications for prevention , 2002, Nature Genetics.

[9]  K. Buetow,et al.  Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression , 1998, International journal of cancer.

[10]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[11]  T. Veenstra,et al.  Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis , 2005, Clinical & Experimental Metastasis.

[12]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[13]  M. Hendrix,et al.  Epigenetic silencing of maspin gene expression in human breast cancers , 2000, International journal of cancer.

[14]  G. Nicolson.  Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. , 1988, Biochimica et biophysica acta.

[15]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[16]  Robert W. Williams,et al.  Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function , 2005, Nature Genetics.

[17]  K. Buetow,et al.  Multiple cross and inbred strain haplotype mapping of complex-trait candidate genes. , 2003, Genome research.

[18]  J. Peterse,et al.  Breast cancer metastasis: markers and models , 2005, Nature Reviews Cancer.

[19]  P. Conte,et al.  The curability of breast cancer and the treatment of advanced disease , 2004, European Journal of Nuclear Medicine and Molecular Imaging.

[20]  N. Crawford,et al.  Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer , 2006, Breast Cancer Research.

[21]  John Quackenbush,et al.  Multiple-laboratory comparison of microarray platforms , 2005, Nature Methods.

[22]  A. Mantovani,et al.  Characterization of tumor lines derived from spontaneous metastases of a transplanted murine sarcoma. , 1981, European journal of cancer.

[23]  R. Carlson,et al.  Goals and objectives in the management of metastatic breast cancer. , 2003, The oncologist.

[24]  Yudong D. He,et al.  A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .

[25]  J. Folkman,et al.  How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. , 1986, Cancer research.

[26]  J. Castle,et al.  An integrative genomics approach to infer causal associations between gene expression and disease , 2005, Nature Genetics.

[27]  E. Liu,et al.  Genetic background is an important determinant of metastatic potential , 2003, Nature Genetics.

[28]  U. Bagge,et al.  Lethal deformation of cancer cells in the microcirculation: A potential rate regulator of hematogenous metastasis , 1992, International journal of cancer.

[29]  K. Broman,et al.  Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. , 2001, Cancer research.

[30]  L. Peters,et al.  Spontaneous metastasis: random or selective? , 1983, Clinical & Experimental Metastasis.

[31]  K. Hunter,et al.  Modifiers of mammary tumor progression and metastasis on mouse Chromosomes 7, 9, and 17 , 2005, Mammalian Genome.

[32]  N. Crawford,et al.  Metastasis Predictive Signature Profiles Pre-exist in Normal Tissues , 2005, Clinical & Experimental Metastasis.

[33]  I. Fidler,et al.  Metastasis results from preexisting variant cells within a malignant tumor. , 1977, Science.

[34]  R. Cardiff,et al.  Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease , 1992, Molecular and cellular biology.

[35]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[36]  D. Welch,et al.  Implications of tumor progression on clinical oncology , 1985, Clinical & Experimental Metastasis.

[37]  D. Ruiter,et al.  Tumour metastasis: is tissue an issue? , 2001, The Lancet. Oncology.

[38]  Robert A. Weinberg,et al.  Metastasis genes: A progression puzzle , 2002, Nature.

[39]  P. Steeg.  Metastasis suppressors alter the signal transduction of cancer cells , 2003, Nature Reviews Cancer.

[40]  L. Holmgren.  Antiangiogenis restricted tumor dormancy , 1996, Cancer and Metastasis Reviews.

[41]  P. Demant,et al.  Cancer susceptibility in the mouse: genetics, biology and implications for human cancer , 2003, Nature Reviews Genetics.

[42]  Andrew I Su,et al.  Uncovering regulatory pathways that affect hematopoietic stem cell function using 'genetical genomics' , 2005, Nature Genetics.

[43]  A. Mantovani,et al.  Metastasizing capacity of tumour cells from spontaneous metastases of transplanted murine tumours. , 1980, British Journal of Cancer.

[44]  V. Robinson,et al.  Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site. , 2003, The Journal of urology.

[45]  Wei He,et al.  Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. , 2005, Proceedings of the National Academy of Sciences of the United States of America.